EBITDA levels soar for well-managed healthcare technology companies

Soaring eagle

As the consultancy.eu website reported last May, private equity buyout deals in the healthcare sector rose to USD63 billion in 2018, a near 50 per cent year-on-year increase, with North America leading the way. And in Europe, PE healthcare specialist investor Global Healthcare Opportunities (GHO Capital Partners) are tapping in to investor demand; its GHO Capital Fund II, which closed in November 2019, attracted EUR975 million, some 50 per cent larger than its inaugural fund in 2015.

With so much innovation and disruption taking place in healthcare and biotechnology, PE groups are working feverishly to uncover value opportunities. And as Jeffrey Stevenson, Managing Partner of US private equity group VSS explains, technology innovation driven by AI, robotics and big data is really driving change in the US healthcare market.  

Author Profile
James Williams
Employee title
Editor-in-Chief

Premium Content

To continue reading this content, please subscribe for free.

SUBSCRIBE